30 January 2012
Abbott is planning to cut around 700 staff in the US and Puerto Rico, with 300 coming from its stent manufacturing division in California, according to media reports. There will be another 200 redundancies at its diagnostics business in Lake County, ...
27 January 2012
Gene sequencing specialist Illumina has launched a "poison pill" defence against Roche 's attempted hostile takeover by adopting a shareholders rights agreement that will serve to dilute the company's stock.
The agreement will be triggered if any ...
27 January 2012
The UK's Human Genomics Strategy Group (HGSG), established as part of the UK government's response to the 2009 House of Lords Inquiry into genomic medicine, has made a series of recommendations that it believes will enable the healthcare system in ...
26 January 2012
Quintiles has invested £3m ($4.7m) in a new company formed in partnership with the University of Oxford and two of its professors, which will provide oncology consulting services and new cancer biomarkers to clients for personalised medicine ...
26 January 2012
UK personalised medicine specialist Lab21 has struck a worldwide licensing deal with Cooperative Diagnostics, giving it exclusive access to real-time PCR technology that should allow it to fast-track the development of its molecular diagnostics ...
